Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Sakurasaku Plus Co's Days Payable or its related term are showing as below:
TSE:7097's Days Payable is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 58.02 * Ranked among companies with meaningful Days Payable only.
Sakurasaku Plus Co's Days Payable
stayed the same
from Jan. 2025 (0.00) to Jan. 2026 (0.00).
stayed the same
The historical data trend for Sakurasaku Plus Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7097 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Sakurasaku Plus Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sakurasaku Plus Co Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sakurasaku Plus Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Sakurasaku Plus Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sakurasaku Plus Co's Days Payable for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sakurasaku Plus Co (TSE:7097) has a Days Payable of 0.00 as of Jan. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sakurasaku Plus Co and its competitors. According to the industry distribution chart, Sakurasaku Plus Co ranks #999999 out of 610 companies in the Healthcare Providers & Services industry.
Is Sakurasaku Plus Co's Days Payable too high?
Sakurasaku Plus Co's current Days Payable is 0.00. Based on the distribution chart, Sakurasaku Plus Co ranks #999999 out of 610 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Sakurasaku Plus Co has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sakurasaku Plus Co's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sakurasaku Plus Co ranks #999999 out of 610 companies for Days Payable. This places Sakurasaku Plus Co in the lower half of its industry. The industry median Days Payable is 58.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.02, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sakurasaku Plus Co and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sakurasaku Plus Co's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sakurasaku Plus Co stock overvalued right now?
Based on GuruFocus' analysis, Sakurasaku Plus Co (TSE:7097) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,606.38, compared to a current price of 円2,729.00 — trading 69.9% above its estimated fair value. The current Days Payable is 0.00. Sakurasaku Plus Co's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sakurasaku Plus Co (TSE:7097), the current Days Payable is 0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sakurasaku Plus Co (TSE:7097) Overvalued in 2026?
Based on GuruFocus' analysis, Sakurasaku Plus Co stock appears to be overvalued.
The current stock price of 円2,729.00 is trading 69.9% above its estimated GF Value™ of 円1,606.38.
GuruFocus considers Sakurasaku Plus Co to be Significantly Overvalued.
Key valuation signals for TSE:7097:
Days Payable: 0.00
GF Value™: 円1,606.38 vs. price of 円2,729.00 (69.9% above fair value)
No single metric tells the full story. See the TSE:7097 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sakurasaku Plus Co Ltd is engaged in the operation and use of childcare daycare centers. The company also provides real estate brokerage and management services. The Group operates in a single segment, the children and childcare support business.
73GF Score
Get the complete analysis for TSE:7097
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7097 has been successfully added to your 
